Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department

Pediatric Emergency Care

Volumn 26, Issue 6, 2010, Pages 424-430

  Phan, Hanna ^a   Leder, Marc ^b,c   Fishley, Matthew ^d   Moeller, Matthew ^e   Nahata, Milap ^b,c,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c Department of Surgery   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Adverse drug event; Off label; Unlicensed

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; DIPHENHYDRAMINE; GLUCOCORTICOID; INFUSION FLUID; LOCAL ANESTHETIC AGENT; MINERAL OIL; PETROLATUM; PSYCHOTROPIC AGENT; SALBUTAMOL;

ARTICLE; CHILD; CONTROLLED STUDY; EMERGENCY CARE; GASTROINTESTINAL SYMPTOM; HOME CARE; HUMAN; INCIDENCE; LICENSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OFF LABEL DRUG USE; PATIENT CARE; PEDIATRICS; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; TACHYCARDIA; ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; EMERGENCY HEALTH SERVICE; FEMALE; RISK FACTOR; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; DRUG TOXICITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; OFF-LABEL USE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 77953361267     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181e057e1     Document Type: Article

References (24)

1. Conroy S. Unlicensed and off-label drug use: issues and recommendations. Pediatr Drugs. 2002;4:363-369.
2. Nahata MC. Inadequate pharmacotherapeutic data for drugs used in children: what can be done? Pediatr Drugs. 1999;4:245-249.
3. Committee on Drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics. 2002;110:181-183.
4. Zuppa AF, Adamson PC, Mondick JT, et al. Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children. J Clin Pharmacol. 2005;45:1305-1312.
5. Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282-290.
6. Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off-label drug use in paediatric wards: prospective study. BMJ. 1998;318: 343-345.
7. Turner S, Gill G, Nunn T, et al. Use of Boff-label[ and unlicensed drugs in paediatric intensive care unit. Lancet. 1996;347:549-550.
8. t' Jong GW, Vulto AG, de Hoog M, et al. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics. 2001;108:1089-1093.
9. t' Jong GW, Vulto AG, de Hoog M, et al. Unapproved and off-label use of drugs in a children's hospital. NEJM. 2000;343:1125-1126.
10. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ. 2000;320:79-82.
11. Conroy S, Peden V. Unlicensed and off label analgesic use in paediatric pain management. Pediatr Anesth. 2001;11:431-436.
12. Bajcetuc M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs used in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775-779.
13. Schrim E, Tobi H, de Jong-van den Berg LT. Risk factors for unlicensed and off-label drug use in children outside the hospital. Pediatrics. 2003;111:291-295.
14. Bücheler R, Schwab M, Mörike K, et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ. 2002;324:1311-1314.
15. Schrim E, Tobi H, de Jong-van den Berg LT. Unlicensed and off label drug use by children in the community: cross sectional study. BMJ. 2002;324:1312-1313.
16. Albano F, Bruzzese E, Spagnuolo MI, et al. Antiemetics for children with gastroenteritis: off label but still on in clinical practice. J Pediatr Gastroenterol Nutr. 2006;43:402-404.
17. Kimland E, Bergman U, Lindemalm S, et al. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr. 2007;166:527-532.
18. Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Safety. 2004;27:1059-1067.
19. Le J, Nguyen T, Law AV, et al. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118:555-562.
20. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296:1858-1866.
21. Committee on the Future of Emergency Care in the United States Health System. Emergency Care for Children, Growing Pains. Executive Summary. The Institute of Medicine. Available at: http://books.nap.edu/ catalog/11655.html. 2007. Accessed June 14, 2008.
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245. (Pubitemid 12149145)
23. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164:552-558.
24. Blumer JL. Off-label uses of drugs in children. Pediatrics. 1999;104: 598-602.